Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines.

Francia G, Emmenegger U, Lee CR, Shaked Y, Folkins C, Mossoba M, Medin JA, Man S, Zhu Z, Witte L, Kerbel RS. Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines. Mol Cancer Ther. 2008 Oct; 7(10):3452-9.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Animals
Cell Line, Tumor
Cell Proliferation
Chorionic Gonadotropin, beta Subunit, Human
Cyclophosphamide
Disease Progression
Female
Humans
Melanoma, Experimental
Mice
Mice, SCID
Neoplasm Metastasis
Receptor, erbB-2
Time Factors
Viscera

authors with profiles

Giulio Francia

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support